The Carcinoembryonic Antigen (CEA) Test has become one of the most important medical tests for monitoring the health of patients and for the early detection of certain types of cancer. This simple, non-invasive test provides accurate indicators of abnormal cells, whether in blood or saliva. In this article, we will explore the importance of the CEA test, its indications, the procedure, how to interpret its results, and its normal range in a simple and straightforward manner, making it your comprehensive guide to understanding this essential diagnostic test.
The Carcinoembryonic Antigen (CEA) test measures the level of the CEA protein in the blood or saliva.
It is used to detect certain types of cancer and monitor patients after treatment.
Cancer detection or suspicion: Especially for cancers of the digestive system, breast, lungs, or pancreas.
Monitoring patients after treatment: To check how the body responds to surgery, chemotherapy, or radiation.
Early detection of tumor recurrence: To identify a possible relapse after treatment.
No, it is non-invasive and simple:
Blood test: A small vein sample is taken.
Saliva test: Collect saliva naturally or by gently chewing a cotton swab.
Usually, fasting is not required, but the doctor may advise avoiding certain foods or drinks before testing.
Low levels or within the normal range usually indicate no significant tumor activity, but do not completely rule out cancer.
Elevated CEA levels may suggest an active tumor.
Additional tests such as biopsy or imaging are always needed to confirm diagnosis.
Presence of an actual tumor.
Non-cancerous conditions like infections of the mouth or colon.
Mouth injuries or ulcers.
Smoking or certain medications and supplements.
Lab errors or sample contamination.
Absence of active tumor or disease.
Some cancers do not secrete CEA clearly into blood or saliva.
Effect of treatments like surgery, chemotherapy, or radiation.
Sample collection errors or contamination.
No, CEA is just a supportive indicator.
Results should always be interpreted with medical history and other tests like biopsy and imaging.
Typically, 1–3 days depending on the sample type (blood or saliva) and the lab.
Yes, it can be repeated regularly to monitor patients after treatment or track early changes in CEA levels.
Blood: 0 – 2.5 ng/mL
Any elevation requires a full medical evaluation to identify the cause.
Procedure:
Preparation: Usually no fasting required, inform the doctor about medications or supplements.
Sample collection: Small blood sample from the arm vein.
Laboratory analysis: Immunoassay techniques measure CEA.
Results: Usually in 1–3 days.
Advantages: Simple, relatively accurate, used for detection and monitoring.
Procedure:
Preparation: Avoid eating or drinking 30–60 minutes before collection, clean mouth well.
Sample collection: Collect natural saliva or after light chewing on a special cotton swab. Place in a sterile tube.
Laboratory analysis: Immunological or molecular techniques detect CEA.
Results: Usually within a few days.
Advantages: Non-invasive, painless, easy to repeat, suitable for early detection.
Procedure:
Sample collection: From fluid around the tumor or other body fluids, often during medical procedures like endoscopy or aspiration.
Laboratory analysis: Advanced immunological methods measure CEA.
Results: Usually 1–5 days depending on fluid type.
Advantages: Indicates tumor activity in a specific site, useful for treatment monitoring.
Follow the doctor’s instructions regarding fasting or medications.
Clean the mouth thoroughly when collecting saliva.
Avoid smoking or alcohol as it may affect results.
Always review results with your doctor; do not rely on the number alone.
Blood CEA (Serum CEA)
Most commonly used for diagnosis and monitoring.
Detects: colon, rectum, breast, lung, pancreas cancers.
Saliva CEA (Salivary CEA)
Non-invasive and painless.
Used for early detection of oral and throat cancers and some upper digestive system tumors.
CEA in Other Body Fluids
Measured in tumor-surrounding fluid or other body fluids (e.g., seminal, pleural, or peritoneal).
Helps assess tumor activity or monitor treatment response in specific areas.
There are multiple subtypes of CEA with varying molecular structures and cell surface characteristics.
Some subtypes are more strongly associated with certain cancer cells than others.
These subtypes are used in early detection research and the development of targeted therapies.
CEA testing is done before treatment, during treatment, and after its completion.
It helps to study how the tumor is responding to treatment compared to previous results.
Though it is not a common diagnostic test, doctors may request it for patients with a family history or genetic syndromes.
Used during treatment to monitor tumor activity in:
Colon
Rectum
Ovaries
Prostate
Lungs
Thyroid
Liver
A decrease in CEA protein levels generally indicates a good treatment response.
After completing treatment, the doctor may request regular CEA tests to monitor for any recurrence of the tumor.
CEA testing helps to determine:
Tumor size
Extent of metastasis to other organs
This information assists in choosing the most appropriate treatment plan.
The CEA test is used to detect cancer proteins or markers in the saliva. It’s usually performed on individuals with potential or risk factors for cancer, including:
When early symptoms appear in the mouth, throat, or salivary glands, such as:
Swelling or lumps in the mouth or neck
Recurrent ulcers or infections that don’t heal
Difficulty swallowing or speaking
The test can help detect cancer before obvious symptoms emerge.
After surgery, chemotherapy, or radiation.
To assess:
Tumor response to treatment
Detect any early relapse
Family history of cancer, especially oral or throat cancers
Continuous smoking or alcohol consumption
Exposure to carcinogenic materials at work or in the environment
When a tumor is discovered, the test helps:
Determine tumor activity
Assess the extent of cancer cell spread
Guide the doctor toward an appropriate treatment plan
CEA should not be relied on alone for cancer diagnosis.
It is used in conjunction with biopsy, imaging, or blood tests to provide a comprehensive and accurate assessment.
The test is simple and non-painful, relying on the collection of saliva for analysis:
Avoid eating or drinking as per the doctor’s instructions (usually for 30–60 minutes).
Clean the mouth thoroughly to avoid contamination.
Remove any removable dental prosthetics or mouth accessories.
Collect natural saliva or stimulate saliva by lightly chewing a special cotton swab.
Place the sample in a sterile tube.
The process is quick and painless, taking just a few minutes.
The sample is stored under specific conditions, typically cold or in a preservative solution.
It is sent directly to the lab for cancer marker analysis.
Immunoassay or molecular analysis techniques are used to detect cancer markers.
The level of cancer markers is measured, indicating the presence of cancer cells or tumor activity.
Normal result: No cancer markers detected in the sample.
Abnormal result: Cancer markers present, and the doctor will likely need:
A biopsy or tissue examination to confirm diagnosis
Additional imaging to locate and measure the tumor
The test can be repeated periodically to monitor the body’s response to treatment or observe any early changes in the tumor.
Follow up with the doctor to decide on the next steps in diagnosis or treatment.
A low reading doesn’t necessarily mean the absence of cancer, but it requires a thorough evaluation of the results:
A low or normal reading suggests that no active cancer cells are present.
Some cancers in the early stages may not release enough CEA to be detected.
After surgery, chemotherapy, or radiation, CEA levels may decrease due to a shrinking tumor.
Low saliva amount or contamination of the sample can lead to a low or inaccurate reading.
Failure to follow instructions such as fasting or cleaning the mouth properly can impact results.
Some cancers don’t release detectable proteins, even if they are present and active.
In such cases, low readings may require further tests such as biopsy or imaging.
Certain medications may suppress the release of cancer markers.
Supplements or herbs sometimes reduce the concentration of proteins in the sample.
Do not rely solely on this test to confirm the absence of cancer.
Follow up with your doctor for additional tests if necessary.
Use the results as part of a comprehensive follow-up plan that includes medical history and other diagnostic tests.
Inflammation at the needle site
Minor bleeding or bruising
Temporary pain during the draw
Dizziness or fainting (rare cases)
Back pain
Mild headache post-test
Dizziness or lightheadedness
Temporary dizziness
Potential damage to intestinal or bladder tissue
Injection site inflammation
Injection site inflammation
Potential bleeding
Possible lung tissue damage
These risks are generally rare and usually occur when there are underlying health problems or failure to follow doctor’s instructions.
CEA analysis measures specific proteins or molecules in saliva or blood, which may indicate cancer cells or tumor activity. The results are interpreted carefully with the doctor’s help, and include:
No clear cancer markers present.
Does not necessarily mean the body is completely free of cancer, but indicates:
Low or absent tumor activity
No detectable cancer cells
The test may be repeated periodically to monitor future changes
Cancer markers present in the sample.
Does not necessarily confirm cancer but requires close monitoring.
Follow-up steps after a positive result:
Retest to rule out errors or contamination
Biopsy to confirm cancer cells
Imaging to locate and measure the tumor (CT or MRI)
Assess risk factors to determine the next steps in diagnosis and treatment
Results are borderline or suspicious.
It’s recommended to repeat the test shortly or use additional tests to clarify.
Goal: Distinguish between a false result or early tumor activity changes.
Type of cancer: Some tumors don’t release markers clearly.
Disease stage: The test is more effective in certain stages.
Mouth and sample cleanliness: Residual food or bacteria can affect the results.
Medications or supplements: Some substances may increase or decrease marker levels.
Don’t panic until a definitive diagnosis is confirmed.
Retest after some time to check for consistency.
Conduct additional tests like biopsy or imaging to determine the cause.
Follow up with the doctor to evaluate all factors before deciding on treatment.